Skip to main content

Disclaimer

You’re about to visit the U.S. Diasorin Liaison NES® site (us.diasorin.com/liaison-nes), intended exclusively for audiences in the United States.
By clicking the button below you confirm that you are aware of entering the U.S site

Go to US site

If you prefer to continue browsing the international (non-U.S.) Diasorin website,
click the button below.

Go to INT Site

Section for healthcare professionals and other qualified operators only. This section contains information about in vitro diagnostic medical devices and is intended exclusively for healthcare professionals and other qualified operators under the applicable rules. By proceeding, you declare that you are a healthcare professional or an equivalent qualified operator and acknowledge that these contents are not intended for the general public.

Newsroom & Events

Explore announcements, partnerships, regulatory milestones, & product updates

LIAISON NES® is expanding point-of-care molecular testing to deliver quality diagnostics closer to patients and enable timely clinical decisions.

newsroom

Latest News & Events

Discover more
Events
ADLM Clinical Lab Expo
Discover more
Download
Press release
McKesson Distribution Partnership Announcement
Download
Download
Press release
LIAISON NES® Flu A/B, RSV & COVID-19 Receives FDA 510(k) Clearance and CLIA Waiver
Download

News & Insights

Download
Group A Strep FDA Submission
Press release
Group A Strep FDA Submission
Download
Download
McKesson Distribution Partnership Announcement
Press release
McKesson Distribution Partnership Announcement
Download
Download
Fisher Distribution Partnership Announcement
Press release
Fisher Distribution Partnership Announcement
Download
Download
LIAISON NES® FLU A/B, RSV & COVID-19 FDA Clearance
Press release
LIAISON NES® Flu A/B, RSV & COVID-19 Receives FDA 510(k) Clearance and CLIA Waiver
Download
Download
LIAISON NES® FLU A/B, RSV & COVID-19 FDA Submission
Press release
LIAISON NES® FLU A/B, RSV & COVID-19 FDA Submission
Download

LIAISON NES® Events and Webinars

Booth #1701
-

ADLM Clinical Lab Expo

Anaheim, California | Americas | Booth #1701
Immunodiagnostics
Luminex LTG
Molecular diagnostics
Find out more
Add to Calendar
Add to Calendar 2026-07-28T00:00:00 2026-07-30T23:59:59 ADLM Clinical Lab Expo <h2>Join Diasorin July 28 - 30 at the 2026 ADLM Clinical Lab Expo - Booth #1701</h2><p><br>Come visit us at <strong>ADLM 2026</strong> in <strong>Anaheim - CA</strong>, where we are excited to share the latest instrumentation and product offerings to help your lab simplify specialty immunodiagnostics and molecular testing, including the Luminex-licensed technology business. Our tests are precise, reliable, and enable early diagnosis, helping improve patient care and outcomes. Stop by <strong>booth #1701</strong> to discover our unique solutions and stay for one (or more) of our engaging in-booth presentations.&nbsp;<br>&nbsp;</p><p><strong>We will host Diasorin Live at ADLM</strong>: A Limited Series Podcast, which will address the challenges laboratories face every day. Join us at our booth to learn about topics ranging from public health threats, flexible options, specialty testing, real-world implementation, and smarter solutions for critical conditions.&nbsp;</p><p>Continue to check this page for more information on the schedule of events.</p><p><strong>We look forward to seeing you in booth #1701!&nbsp;</strong>&nbsp;</p> Anaheim, California Diasorin diasorin@nomail.com America/Los_Angeles public
-

APIC26

Nashville, Tennessee | Americas
Molecular diagnostics
Find out more
Add to Calendar
Add to Calendar 2026-06-15T00:00:00 2026-06-17T23:59:59 APIC26 <p><span style="font-size:14.0pt;line-height:115%;"><strong>Join us at APIC 2026 June 15-17 in Nashville!</strong></span></p><p>We are proud to participate in APIC 2026, where infection prevention professionals come together to address emerging threats, share best practices, and advance patient safety.</p><p>At this year’s meeting, we will be featuring Simplexa<sup>®</sup> <em>C. auris</em> Direct, the first FDA-authorized assay for <em>Candida auris</em> detection, and highlighting how rapid, onsite PCR testing can support timely decision-making, smarter isolation strategies, and improved patient flow when managing <em>C. auris</em>; stop by the <strong>Diasorin Booth #1411</strong> to learn more and see how these innovations can elevate your infection control strategies.</p><p>&nbsp;</p><p>Join us at our <strong>Exhibitor Theater Session</strong> on June 16th for a discussion on <em>C. auris</em>!</p><p><strong>Test Faster, Isolate Smarter:</strong> Improving Patient Flow While Containing <em>C. auris</em></p><p><strong>Speaker</strong></p><div style="align-items:flex-start;display:flex;gap:16px;"><img src="/sites/default/files/inline-images/Sarah%20Elliott%20Headshot.jpg" data-entity-uuid="20f4ee7f-8451-40a4-9715-2b716113054b" data-entity-type="file" width="137" height="194"><div><strong>Dr. Sarah Elliot</strong><br>Sr. Principal Scientist, Diasorin Scientific Affairs</div></div><p><br>&nbsp;</p><p>Date: Tuesday, June 16<br>Time: 12:45 PM CST<br>Location: Exhibit Hall – Exhibitor Theater</p><p><em>C. auris</em> continues to present significant challenges for healthcare facilities due to its high transmissibility, environmental persistence, and frequent resistance to antifungal therapy. Rapid identification and informed isolation decisions are critical to reducing spread while maintaining operational efficiency.</p><p>Join Dr. Sarah Elliott, Sr. Principal Scientist, Diasorin Scientific Affairs, for a timely, interactive session exploring how onsite PCR testing can support infection prevention teams by helping to:</p><ul style="list-style-type:disc;"><li style="tab-stops:list .5in;">Improve patient flow and cohorting</li><li style="tab-stops:list .5in;">Reduce transmission risk</li><li style="tab-stops:list .5in;">Lower institutional and operational costs</li></ul> Nashville, Tennessee Diasorin diasorin@nomail.com UTC public

Follow Diasorin Events

Find out more